Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patients.

Psychopharmacology - 1 Oct 2009

Alkelai Ana, Greenbaum Lior, Rigbi Amihai, Kanyas Kyra, Lerer Bernard

Abstract excerpt

RATIONALE: Antipsychotic-induced parkinsonism (AIP) is a severe adverse affect of neuroleptic treatment. Interindividual heterogeneity in AIP development and severity is associated with risk factors such as antipsychotic drug type, old age, and female gender. There is evidence for genetic predisposition to develop AIP but the variants that confer susceptibility or protection are mostly unknown. OBJECTIVE: To...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Logistic Models
Share to Parkinson Disease, Secondary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Randomized Controlled Trials as Topic

Share to Schizophrenia

Share to Severity of Illness Index

Share to United States

Source

Identifiers

PMID: 19680635
DOI: 10.1007/s00213-009-1627-z

Genes

AIP
FIGN
NOVA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patients.PMID 19680635Read ↗

Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patients.Semantic proximity Read ↗

Genomewide association study of movement-related adverse antipsychotic effects.Semantic proximity Read ↗

Integrating Genome-wide and Epigenome-wide Associations for Antipsychotic Induced Extrapyramidal Side EffectsSemantic proximity Read ↗

Integrating genome-wide and epigenome-wide associations for antipsychotic induced extrapyramidal side effects.Semantic proximity Read ↗

A genetic dissection of antipsychotic induced movement disorders.Semantic proximity Read ↗

Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic PatientsSemantic proximity Read ↗

Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features.Semantic proximity Read ↗

Identifying genetic contributions of 6q21 loci and PPAR pathway to antipsychotic-induced metabolic syndrome: a Sex-Stratified Multi-Omics study.Semantic proximity Read ↗

Genetic variations of PIP4K2A confer vulnerability to poor antipsychotic response in severely ill schizophrenia patients.Semantic proximity Read ↗

Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disordersSemantic proximity Read ↗

Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment.Semantic proximity Read ↗

Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorderSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.